XOMA Royalty CorpXOMA
Price$40.17Intrinsic value$14.3964% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $14.39median of 3 methodsbased on filings through 31 Mar 2026
Market Price $40.17Price as of 13 Jul 2026
Margin of Safety -64.2%as of 13 Jul 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 5.0%/yr (balance of the path).5.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 65.0%Yr 75.0%Yr 85.0%Yr 95.0%Yr 105.0%
5.0% → 5.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 114.8%Yr 124.6%Yr 134.4%Yr 144.2%Yr 154.0%Yr 163.8%Yr 173.6%Yr 183.4%Yr 193.2%Yr 203.0%
5.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 1 window (5y) (limited history)13.4%
Discount rate (cost of equity) 9.0%
Volatility vs market (adjusted beta)0.91

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetXOMA Royalty CorpXOMAHealth Care
Valuation
P/E25.6×
P/S68.6×
P/B7.6×
EV / Revenue70.3×
EV / EBITDA70.4×
Profitability
Gross margin100.0%
Operating margin21.8%
Net margin326.7%
FCF margin65.4%
Returns
ROE36.4%
ROA12.4%
ROIC30.7%
Growth
Revenue growth (YoY)55.6%
5-yr fwd EPS growth—
Financial strength
Debt / Equity1.11×
Current ratio3.59×
Altman Z-Score-3.1
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.